Post

New research · Hematology
Current oncology (Toronto, Ont.) · 4d
GuidelineCurrent oncology (Toronto, Ont.) · 2026

Management of Acute Myeloid Leukemia in Older Patients: An Updated Canadian Consensus.

Andre C Schuh, Nicholas Chornenki, Mohamed A Elemary … Joseph Brandwein
Read paper
HematologyGuideline
“

As more new targeted agents become available and hypomethylating agent-based triplet combinations are used more widely, we fully anticipate that we will, in some years' time, write a fourth guideline on the management of acute myeloid leukemia in older patients.

Management of Acute Myeloid Leukemia in Older Patients: An Updated Canadian Consensus.

Andre C Schuh … Joseph Brandwein
Current oncology (Toronto, Ont.) · 2026
Background

These are the third Canadian consensus guidelines on the management of acute myeloid leukemia (acute myeloid leukemia) in older patients.

More results

The first was published in 2013, and the second in 2017.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Case-control
AUC = 0.94
CXCL9 levels accurately distinguish acute myeloid leukemia that resists treatment from remission
Cohort Study
AUC 0.939
Neutrophil-to-lymphocyte ratio is excellent at predicting who will get lung problems after bypass surgery
Guideline
>95%
most Hairy Cell Leukemia patients have a specific gene change causing their cancer
AI / Informatics
10.92%
Paroxysmal nocturnal haemoglobinuria was diagnosed in high-risk patients referred for testing by AI screening
Cohort Study
49%
Nearly half of patients had problems 30 days after spleen removal for blood cancer
Cohort Study
OR: 0.89
GLP-1RA users had slightly lower odds of Hodgkin's lymphoma than DPP-4i users
Cohort Study
adjusted hazard ratio 1.917
Patients with leukoerythroblastosis had a 1.9-fold higher hazard of 90-day death.
Cohort Study
OR 3.95
flexible sigmoidoscopy makes it almost 4 times more likely to find gastrointestinal GvHD